Answers are grounded in this paper and cite their sources.
Introduction Adiponectin (APO) and proinsulin (P-INS) are commonly used biomarkers in patients with metabolic diseases such as diabetes mellitus (DM) and metabolic syndrome. Both markers have intensively been investigated for their role in metabolic disorders. The liver plays an important part during the pathogenesis of different metabolic diseases like i.e., nonalcoholic
No takes yet. Share an insight, caveat, or question.
Malinowski et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: